Amido compounds and their use as pharmaceuticals
US7304081B2 · kind B2 · utility
31Cited by
9References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2005 |
| Grant date | Dec 4, 2007 |
| Priority date | — |
| Expiry date | Oct 14, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.